Hypertension (High Blood Pressure) News and Research

RSS

Hypertension (or high blood pressure) is a condition where the pressure of the blood flowing through the arteries of the body is higher than it should be. Much like the pressure of the air in a tire, if the pressure of the blood is too high it can damage the arteries and organs of the body. Just like the tire, if the pressure suddenly becomes very high, catastrophic events can happen. Similarly, if the pressure remains somewhat elevated for a long enough period of time, premature wear and failure can occur.

Hypertension has its worst effects on the heart, kidneys, eyes, and brain. High blood pressure is a risk factor for heart attack, stroke, kidney failure, hemorrhages of the retina of the eye, and generalized atherosclerosis (hardening of the arteries all over the body).

Isradipine shown to slow down Parkinson's disease

Northwestern University researchers have discovered a drug that slows and may even halt the progression of Parkinson's disease.

14 Jun 2007

Addressing multiple unhealthy behaviors at once may be more effective than sequential approach

Physicians trying to help patients change more than one behavioral risk factor may have more success approaching several topics at once rather than addressing them separately over time, according to a report in the June 11 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

14 Jun 2007

Cure for Parkinson's disease?

Scientists in the U.S. say they have discovered a drug that slows and might even stop the progression of Parkinson's disease.

11 Jun 2007

New genes involved in rheumatoid arthritis discovered

Researchers at the University of Manchester have identified evidence of several new genes behind the chronic inflammatory disease rheumatoid arthritis (RA), which affects 387,000 people in the UK.

From The University of Manchester 8 Jun 2007

Largest ever genetics study of common diseases

The Wellcome Trust Case Control Consortium, the largest ever study of the genetics behind common diseases such as diabetes, rheumatoid arthritis and coronary heart disease, publishes its results in the journals Nature and Nature Genetics.

8 Jun 2007

VEGF Trap (aflibercept) shows activity in patients with advanced ovarian cancer

Preliminary results of a randomized, international Phase II trial of VEGF Trap (aflibercept) show activity in patients with recurrent epithelial ovarian cancer (EOC) who had received three or four prior chemotherapy regimens and had become resistant to platinum-based chemotherapy agents.

5 Jun 2007

Axitinib shows promise in treatment of advanced thyroid cancer

The investigational drug axitinib produced tumor regression or stable disease in almost three-out-of-four patients with advanced thyroid cancer, a research team reported at the annual meeting of the American Society for Clinical Oncology in Chicago.

5 Jun 2007

Herceptin does not increase heart failure in patients long-term

Risk of congestive heart failure in women treated with trastuzumab (Herceptin) and combination chemotherapy for early-stage breast cancer did not increase over time according to a five-year follow-up of National Surgical Adjuvant Breast and Bowel Project (NSABP) trial B-31, presented at the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago.

5 Jun 2007

Results of phase II studies of pazopanib

GlaxoSmithKline (GSK) has announced results from ongoing Phase II studies of pazopanib in advanced or metastatic renal cell carcinoma (RCC) and ovarian cancer.

5 Jun 2007

Research explains why those with obstructive sleep apnea are at higher risk for cardiovascular disease

Researchers have found that patients with obstructive sleep apnea (OSA) have higher levels of a type of dead cells (apoptotic cells) from the lining (endothelium) of their blood vessels circulating in their bloodstream than people who do not have OSA.

3 Jun 2007

Longer CPAP use at night can normalize one's daytime functioning

A study published in the June 1st issue of the journal SLEEP finds that longer nightly duration of continuous positive airway pressure (CPAP) use can help those suffering from obstructive sleep apnea (OSA) achieve normal daytime functioning.

3 Jun 2007

FDA approves Norditropin for short stature in children with Noonan syndrome

Novo Nordisk has announced that Norditropin (somatropin[rDNA origin] injection) received U.S. Food and Drug Administration (FDA) approval for the treatment of short stature in children with Noonan syndrome.

3 Jun 2007

Researchers to discuss gene that may be linked to polycystic ovary syndrome

Researchers in endocrinology and obstetrics and gynecology at Cedars-Sinai Medical Center will make several presentations at the upcoming annual meetings of two medical organizations , the Androgen Excess Society (June 1, 2007) and the Endocrine Society (June 2-5, 2007).

3 Jun 2007

Cytomegalovirus exacerbates atherosclerosis through an autoimmune mechanism

A new study conducted by researchers from the University of Verona and the Institute G. Gaslini in Genova, Italy, confirms the pivotal role played by Cytomegalovirus infection in the pathogenesis of atherosclerosis.

1 Jun 2007

Better guidelines on the use of mobile phones in the provision of clinical care urgently needed

Healthcare systems are increasing looking to developments in mobile communication technology to help improve the provision of care to people with long-term conditions, such as diabetes, asthma, hypertension and coronary heart disease.

30 May 2007

Soy nuts lower blood pressure in postmenopausal women

Substituting soy nuts for other protein sources in a healthy diet appears to lower blood pressure in postmenopausal women, and also may reduce cholesterol levels in women with high blood pressure, according to a report in the May 28 issue of Archives of Internal Medicine.

30 May 2007